In 2024, JD Health Limited released its interim report, showing that its revenue for the first half of the year reached 28.3 billion Chinese yuan, a year-on-year growth of 4.6%. As of June 30, 2024, the number of active users reached 181 million, with a daily average of over 0.48 million online consultations. During the reporting period, JD Health continued to strengthen its operation model of integrating self-operated, online platforms, and real-time retail, and expanded cooperation with leading pharmaceutical companies and health product suppliers in the industry. In addition, JD Health actively promoted the application innovation of technologies such as medical big data in medical and health services, enhancing the quality and efficiency of online medical services. The profit for the period was 2,034.4 million Chinese yuan, and the acquisition of the remaining 51% equity of Tangshan Hongci Medical Management Co., Ltd. was terminated after the reporting period.

In 2024, JD Health Limited released its interim report, showing that its revenue for the first half of the year reached 28.3 billion Chinese yuan, a year-on-year growth of 4.6%. As of June 30, 2024, the number of active users reached 181 million, with a daily average of over 0.48 million online consultations. During the reporting period, JD Health continued to strengthen its operation model of integrating self-operated, online platforms, and real-time retail, and expanded cooperation with leading pharmaceutical companies and health product suppliers in the industry. In addition, JD Health actively promoted the application innovation of technologies such as medical big data in medical and health services, enhancing the quality and efficiency of online medical services. The profit for the period was 2,034.4 million Chinese yuan, and the acquisition of the remaining 51% equity of Tangshan Hongci Medical Management Co., Ltd. was terminated after the reporting period.